This is a community-generated profile. If you work at Achieve Life Science, to claim it.

Developing cytisinicline as a pharmaceutical treatment for nicotine dependence and smoking cessation51-200 Employees
- Recently fundedRaised funding in the past six months
Achieve Life Science Funding
$150M
11 round
Achieve Life Science has secured funding across 1 rounds, totaling in an amount of $150M. Their most recent funding was raised on August 14, 2026.
Funding Rounds
S
$150000000